Bristol Myers Squibb (CELG-RI) Times Interest Earned (2012 - 2013)
Bristol Myers Squibb (CELG-RI) reported Times Interest Earned of -$7.78 for Q1 2013, down 145.13% year-over-year from $17.24 in Q1 2012, and down 145.13% quarter-over-quarter from $17.24 in Q1 2012.
Bristol Myers Squibb (CELG-RI) Times Interest Earned (2012 - 2013) Analysis & Trends
Bristol Myers Squibb (CELG-RI) has 2 years of Times Interest Earned data on file, last reported at -$7.78 in Q1 2013.
- Times Interest Earned for Q1 2013 came in at -$7.78, down 145.13% year-over-year; the trailing twelve-month figure through Dec 2013 was -$34.56 (up 36.06% YoY), and the FY2012 annual result was $4.5, down 73.29% from the prior year.
- Times Interest Earned slipped to -$7.78 in Q1 2013 per CELG-RI's latest filing, from $17.24 in the prior quarter.
- Over five years, Times Interest Earned peaked at $17.24 in Q1 2012 and troughed at -$7.78 in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | -13.73 |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 23.39 |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | - |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | - |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | - |
| 10 | Bristol Myers Squibb | - | - | 8.07 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | -7.78 |
| Mar 31, 2012 | 17.24 |